Treatment of advanced cancer of the prostate with an analog of LHRH, buserelin
Wenderoth, U.K.; Jacobi, G.H.
Annales d'Urologie 20(2): 95-97
1986
ISSN/ISBN: 0003-4401 PMID: 3087269 Document Number: 274990
Patients with metastatic prostatic cancer were treated by means of an LHRH agonist, Buserelin, by nasal administration. The serum testosterone levels were permanently decreased to castration levels in all patients. The objective response rate (CR + PR) was 50%.
Document emailed within 1 workday
Related Documents
Schumacher, T.; Zwirner, M.; Unterberg, H.; Pohl, C.; Keller, E.; Schindler, A.E. 1984: Effects of the lhrh analog buserelin given discontinuously as a contraceptive on ovarian cycle and lipometabolism Neuro Endocrinology Letters 6(5): 267-272De Voogt, H.J.; Adenauer, H.; Widdra, W.G. 1991: The use of the LHRH-analogue Buserelin in the treatment of prostatic cancer. a 10-year review on 1522 patients treated in 119 centres on 4 continents Scandinavian Journal of Urology and Nephrology. Supplementum 138: 131-136
Okuda, K.; Ushiroyama, T.; Yoshikawa, M.; Sugimoto, O. 1988: Effect of LHRH agonist (buserelin) on pulsatile secretion of LHRH and LH Nihon Sanka Fujinka Gakkai Zasshi 40(12): 1889-1893
Keizman, D.; Eisenberger, M.A. 2009: LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy? Oncology 23(7): 631-632
Debruyne, F.M.; Karthaus, H.F.; Schröder, F.H.; de Voogt, H.J.; de Jong, F.H.; Klijn, J.G. 1985: Results of a Dutch Phase Ii trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer Progress in Clinical and Biological Research 185a: 251-270
Litjens, T.T.; Fernandez del Moral, P.; van Laarhoven, J.P.; Weil, E.H.; Debruyne, F.M. 1986: Treatment of advanced prostate carcinoma with a depot form of an LH-RH analog: preliminary endocrinological and clinical results Nederlands Tijdschrift Voor Geneeskunde 130(17): 787-790
Crawford, E.D.; Hou, A.H. 2009: The role of LHRH antagonists in the treatment of prostate cancer Oncology 23(7): 626-630
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62
Bessoule, O.; Le Loët, X.; Deshayes, P. 1988: Importance of analogs of LHRH in the treatment of bone metastasis of cancer of the prostate in 1988 Revue du Rhumatisme et des Maladies Osteo-Articulaires 55(11): 885-887
Dondi, D.; Limonta, P.; Moretti, R.M.; Marelli, M.M.; Garattini, E.; Motta, M. 1994: Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop Cancer Research 54(15): 4091-4095
Brauner, R.; Rappaport, R. 1987: Treatment of central precocious puberty with an LHRH analog. Effect on growth and bone maturation after 2 years of treatment Archives Francaises de Pediatrie 44(4): 271-276
Abbou, C.C.; Lucas, C.; Leblanc, V. 1997: Tolerance and clinical and biological responses during the first 6 months of treatment with 1-month sustained release LHRH agonists leuprolerin and triptolerin in patients with metastatic prostate cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(6): 984-995
Stromberg, J.S.; Martinez, A.A.; Horwitz, E.M.; Gustafson, G.S.; Gonzalez, J.A.; Spencer, W.F.; Brabbins, D.S.; Dmuchowski, C.F.; Hollander, J.B.; Vicini, F.A. 1997: Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment Cancer Journal from Scientific American 3(6): 346-352
Orovan, W.L. 1989: Treatment of advanced cancer of the prostate Canadian Journal of Surgery. Journal Canadien de Chirurgie 32(5): 315-316
Wilking, N.; Rutqvist, L.E. 1990: LHRH analogs versus orchidectomy in prostate cancer Lakartidningen 87(16): 1344-1345
Debruyne, F.M.; Fernandez del Moral, P.; Geboers, A.D. 1988: LHRH-analogues therapy for metastatic prostate cancer Progress in Clinical and Biological Research 260: 27-39
Faris, G.; Stein, A.; Lurie, A. 1993: Hormonal treatment of advanced prostate cancer Harefuah 124(1): 35-40
Swanson, G.P. 2007: Treatment options in locally advanced prostate cancer Minerva Urologica e Nefrologica 59(1): 27-42
Mulders, P.F. 1999: Treatment of advanced prostate cancer: the vaccine approach Scandinavian Journal of Urology and Nephrology. Supplementum 203: 41-43
Azuma, H.; Katsuoka, Y. 2006: Treatment for locally advanced prostate cancer: value of surgery Hinyokika Kiyo. Acta Urologica Japonica 52(6): 459-467